Advanced Biomed Inc. (ADVB) vs Inotiv, Inc. (NOTVQ)

Advanced Biomed Inc. and Inotiv, Inc. are both Diagnostics & Research companies. Advanced Biomed Inc. is the larger, with a market value of $8.1M against $2.8M — 2.9× the size. Inotiv, Inc. has negative trailing earnings, so its P/E is not meaningful; Advanced Biomed Inc. trades at 0.8×. Advanced Biomed Inc. has the higher net margin (0.00% vs −17.1%) and the lower return on invested capital (−33.4% vs −6.19%). Across the 13 metrics below, Advanced Biomed Inc. leads on 11 and Inotiv, Inc. on 2.

Valuation

Metric ADVB NOTVQ Diagnostics & Research median
P/E 0.77 n/m 35.56
P/S n/m 0.00 4.37
P/B 0.41 0.00 3.06
Price to free cash flow n/m n/m 35.76
EV/EBITDA n/m 60.99 24.35
EV/Sales n/m 1.57 5.51
Earnings yield 129.37% (25,300.00%) (1.89%)
Free cash flow yield (90.81%) (2,858.05%) (0.15%)

Profitability

Metric ADVB NOTVQ Diagnostics & Research median
Gross margin — 22.94% 50.89%
Operating margin 0.00% (9.48%) (8.57%)
Net margin 0.00% (17.14%) (6.37%)
Free cash flow margin 0.00% (1.95%) 0.00%
Return on equity 84.77% (74.09%) (2.92%)
Return on assets 36.47% (11.85%) (6.71%)
Return on invested capital (33.43%) (6.19%) 0.00%

Growth

Metric ADVB NOTVQ Diagnostics & Research median
Revenue growth (TTM) — 5.61% 7.69%
EPS growth (last fiscal year) 266.53% 49.64% 25.92%
Revenue growth, 5-year CAGR — 53.36% 7.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ADVB NOTVQ Diagnostics & Research median
Debt to equity 0.00 5.49 0.11
Current ratio 9.33 0.27 2.02
Net debt to EBITDA 0.06 12.68 0.70

Dividend

Metric ADVB NOTVQ Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric ADVB NOTVQ Diagnostics & Research median
Market cap 8.06m 2.79m 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack